Octave Bioscience
Angela Sanchez, MSN, FNP-C, MSCN began their career in 2003 as a Critical Care Registered Nurse at OhioHealth, where they worked in the Trauma-Surgical ICU and CVU/CVICU/CCL. In 2007, they moved to AMN Healthcare, where they provided high level nursing care to critically ill patients in the Medical Cardiac ICU. In 2012, they became a Critical Care Registered Nurse for Presbyterian Healthcare Services' Medical Evaluation Team (MET). In 2008, they joined The University of New Mexico Health Sciences Center as an Interventional Radiology Unit Based Educator, where they trained medical staff, nurse residents, and new hires, as well as assisted in the development of neurology and stroke protocols for Stroke Center certification. In 2017, they joined IQVIA as a Multiple Sclerosis Field Nurse Educator. In 2021, they moved to Amplity Health, where they worked as a Medical Affairs Patient Diagnosis Liaison in the Metabolics/XLH disease state. In 2022, they were promoted to a Medical Affairs Patient Diagnosis Liaison in Neurology at Ultragenyx Pharmaceutical Inc. In 2019, they became a Family Nurse Practitioner at Cardinal Care LLC. In 2023, they joined Octave as a Medical Science Liaison, where they served as a source of reliable scientific information regarding the Octave Bioscience Solution for Neuro degenerative disease/multiple sclerosis and established/maintained relationships with key opinion leaders (KOLs).
Angela Sanchez, MSN, FNP-C, MSCN has a diverse educational background. Angela received their Registered Nurse ASN from OSU/MTC in 2003, their Bachelor's degree in Registered Nursing/Registered Nurse from The University of New Mexico in 2014, and their Master's degree in Family Practice Nurse/Nursing from Chamberlain University in 2018. Angela is also certified as a Family Nurse Practitioner (FNP) from the American Academy of Nurse Practitioners Certification Board (AANPCB) and as a Multiple Sclerosis Certified Specialist (MSCS) from IOMSN.
This person is not in any offices
Octave Bioscience
Octave Bioscience’s Comprehensive Care Platform provides a quantitative, objective measurement system designed to expand clinical insights in neurodegenerative disease, beginning with MS. It provides multiple layers of insight to provide a 360 degree view with a longitudinal perspective of disease progression. The first layer measures the patient’s underlying biology with blood based biomarkers that quantitatively and objectively assess inflammation and immune modulation. The second layer includes advanced measurement using improved MRI readings and interpretation to reveal more insights at the CNS layer, including the brain and spine. The final layer features real time tracking of symptoms via monitoring with mobile tools, sensors and wearables to identify changes in disease and alert care teams. All of this data is integrated into protocols, supported by decision support tools and feeds into a dashboard for ease of use. The Octave Platform allows individual and population views to facilitate better stratification and contextual interventions.